TBPH Annual Gross Profit
N/A
31 December 2023
Summary:
TBPH annual gross profit is not available.TBPH Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TBPH Quarterly Gross Profit
N/A
30 September 2024
Summary:
TBPH quarterly gross profit is not available.TBPH Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TBPH TTM Gross Profit
N/A
30 September 2024
Summary:
TBPH TTM gross profit is not available.TBPH TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TBPH Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
TBPH Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Theravance Biopharma Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $59.66 M(+537.6%) | $15.11 M(+24.5%) | $59.66 M(+29.8%) |
| Sept 2018 | - | $12.13 M(-51.3%) | $45.95 M(+23.8%) |
| June 2018 | - | $24.92 M(+232.6%) | $37.11 M(+159.0%) |
| Mar 2018 | - | $7.49 M(+435.6%) | $14.33 M(+53.1%) |
| Dec 2017 | $9.36 M(-79.6%) | $1.40 M(-57.5%) | $9.36 M(-25.2%) |
| Sept 2017 | - | $3.29 M(+53.4%) | $12.50 M(-55.3%) |
| June 2017 | - | $2.15 M(-14.9%) | $27.96 M(-8.8%) |
| Mar 2017 | - | $2.52 M(-44.5%) | $30.64 M(-33.0%) |
| Dec 2016 | $45.75 M(+22.1%) | $4.55 M(-75.7%) | $45.75 M(+9.2%) |
| Sept 2016 | - | $18.74 M(+287.8%) | $41.90 M(+25.9%) |
| June 2016 | - | $4.83 M(-72.6%) | $33.27 M(-5.1%) |
| Mar 2016 | - | $17.63 M(+2448.0%) | $35.07 M(-6.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | $37.47 M(+391.1%) | $692.00 K(-93.2%) | $37.47 M(+7.1%) |
| Sept 2015 | - | $10.12 M(+52.6%) | $34.99 M(+13.5%) |
| June 2015 | - | $6.63 M(-66.9%) | $30.84 M(+14.6%) |
| Mar 2015 | - | $20.03 M(-1219.6%) | $26.90 M(+252.6%) |
| Dec 2014 | $7.63 M(+3276.1%) | -$1.79 M(-130.0%) | $7.63 M(-20.5%) |
| Sept 2014 | - | $5.97 M(+121.4%) | $9.59 M(+162.8%) |
| June 2014 | - | $2.69 M(+256.0%) | $3.65 M(+279.9%) |
| Mar 2014 | - | $757.00 K(+332.6%) | $961.00 K(+325.2%) |
| Dec 2013 | $226.00 K(-99.8%) | $175.00 K(+629.2%) | $226.00 K(+343.1%) |
| Sept 2013 | - | $24.00 K(+380.0%) | $51.00 K(+88.9%) |
| June 2013 | - | $5000.00(-77.3%) | $27.00 K(+22.7%) |
| Mar 2013 | - | $22.00 K | $22.00 K |
| Dec 2012 | $130.15 M | - | - |
FAQ
- What is the all time high annual gross profit for Theravance Biopharma?
- What is the all time high quarterly gross profit for Theravance Biopharma?
- What is the all time high TTM gross profit for Theravance Biopharma?
What is the all time high annual gross profit for Theravance Biopharma?
Theravance Biopharma all-time high annual gross profit is $130.15 M
What is the all time high quarterly gross profit for Theravance Biopharma?
Theravance Biopharma all-time high quarterly gross profit is $24.92 M
What is the all time high TTM gross profit for Theravance Biopharma?
Theravance Biopharma all-time high TTM gross profit is $59.66 M